Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors
- PMID: 31223209
- PMCID: PMC6563661
- DOI: 10.6026/97320630014499
Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors
Abstract
The abnormal activation of AKT/mTOR signaling pathway and overexpression of LMTK3, are the main factors involved in the generation of drug resistance. Therefore, the use of computer-aided drug design in the inhibitors discovery offers an advantage to provide new candidates for the treatment of this resistance. We realised the virtual screening and molecular docking of AKT1 and LMTK3 proteins by the Dockblaster server. In addition, with abundance of candidates under development for AKT1 kinase, we have also conducted a Quantitative Structure-Activity Relationship (QSAR) study based on these compounds, in order to design more active compounds and predict their activity for development of a new inhibitor of AKT1. QSAR tests were performed for AKT1 using the Partial Least Squares method with a correlation coefficient of R2=0.8062 and a cross-validation of q2=0.6995. This test has selected five compounds as competitive inhibitors-AKT1-ATP with a better biological activities. In parallel the molecular screening has selected five other compounds as competitive ATP-inhibitors of LMTK3. One of them is a common inhibitor with AKT1, and it is marketed as a moderate to severe pain therapy. The ADME predictions confirmed the inhibitors pharmacological activity of these compounds for potential consideration as drug candidates.
Keywords: AKT1; ATP-inhibitors; LMTK3; QSAR; Virtual screening.
Figures
Similar articles
-
Computer-Aided Identification of Kinase-Targeted Small Molecules for Cancer: A Review on AKT Protein.Pharmaceuticals (Basel). 2023 Jul 11;16(7):993. doi: 10.3390/ph16070993. Pharmaceuticals (Basel). 2023. PMID: 37513905 Free PMC article. Review.
-
Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.BMC Pharmacol Toxicol. 2021 Nov 2;22(1):68. doi: 10.1186/s40360-021-00512-y. BMC Pharmacol Toxicol. 2021. PMID: 34727985 Free PMC article.
-
Structure-Based Virtual Screening of High-Affinity ATP-Competitive Inhibitors Against Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: A Novel Therapeutic Target for Breast Cancer.Interdiscip Sci. 2019 Sep;11(3):527-541. doi: 10.1007/s12539-018-0302-7. Epub 2018 Jul 31. Interdiscip Sci. 2019. PMID: 30066129
-
3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.Comb Chem High Throughput Screen. 2017 Aug 10;20(4):292-303. doi: 10.2174/1386207320666170427143858. Comb Chem High Throughput Screen. 2017. PMID: 28460621
-
Systematic generation of chemical structures for rational drug design based on QSAR models.Curr Comput Aided Drug Des. 2011 Mar;7(1):1-9. doi: 10.2174/157340911793743556. Curr Comput Aided Drug Des. 2011. PMID: 20550510 Review.
Cited by
-
The multifaceted role of lemur tyrosine kinase 3 in health and disease.Open Biol. 2021 Sep;11(9):210218. doi: 10.1098/rsob.210218. Epub 2021 Sep 29. Open Biol. 2021. PMID: 34582708 Free PMC article. Review.
-
AKT1 Polymorphism (rs10138227) and Risk of Colorectal Cancer in Moroccan Population: A Case Control Study.Asian Pac J Cancer Prev. 2020 Nov 1;21(11):3165-3170. doi: 10.31557/APJCP.2020.21.11.3165. Asian Pac J Cancer Prev. 2020. PMID: 33247671 Free PMC article.
-
Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules.Bioinform Biol Insights. 2020 Oct 21;14:1177932220965505. doi: 10.1177/1177932220965505. eCollection 2020. Bioinform Biol Insights. 2020. PMID: 33149560 Free PMC article.
-
In silico and in vitro approaches to evaluate the bioactivity of Cassia auriculata L extracts.IET Nanobiotechnol. 2020 May;14(3):210-216. doi: 10.1049/iet-nbt.2019.0364. IET Nanobiotechnol. 2020. PMID: 32338629 Free PMC article.
-
Use of QSAR Global Models and Molecular Docking for Developing New Inhibitors of c-src Tyrosine Kinase.Int J Mol Sci. 2019 Dec 18;21(1):19. doi: 10.3390/ijms21010019. Int J Mol Sci. 2019. PMID: 31861445 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous